SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

Morgan Stanley Maintains Equal-Weight on Biohaven Pharmaceutical, Raises Price Target to $63

Morgan Stanley maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Equal-Weight and raises the price target from $57 to $63.

· 10/13/2020 08:30
Morgan Stanley maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Equal-Weight and raises the price target from $57 to $63.